These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3780446)

  • 1. [Renal artery spasm following thrombosis prevention with heparin/DHE].
    Meybier H; Krämer KL; Allenberg JR; Terweg B
    Dtsch Med Wochenschr; 1986 Nov; 111(46):1781-2. PubMed ID: 3780446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial spasm caused by administration of DHE-heparin in a tibial fracture].
    Hertz H; Wruhs O; Polterauer P
    Aktuelle Traumatol; 1984 Aug; 14(4):142-5. PubMed ID: 6147974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The problem of ergotism in thrombosis prevention with drugs].
    Räber G; Bauermeister U
    Z Arztl Fortbild (Jena); 1983; 77(23):965-8. PubMed ID: 6670300
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral upper extremity ischemia after administration of dihydroergotamine-heparin for prophylaxis of deep venous thrombosis.
    Seifert KB; Blackshear WM; Cruse CW; Schwartz JA; Suslavitch F
    J Vasc Surg; 1988 Oct; 8(4):410-4. PubMed ID: 3139897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
    Borris LC; Lassen MR; Christiansen HM; Møller-Larsen F; Knudsen VE; Nielsen BW
    Ugeskr Laeger; 1988 Jul; 150(27):1682-3. PubMed ID: 3388590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiospasm and dihydroergotamine--dangers in thromboprevention].
    Schwering H; Rühland D
    Zentralbl Chir; 1985; 110(18):1115-21. PubMed ID: 4082802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Vasa; 1983; 12(1):64-7. PubMed ID: 6837130
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular spasm during heparin-dihydroergotamine prophylaxis.
    Kilroy RA; Aull LD; Ellis LM
    Clin Pharm; 1987 Jul; 6(7):575-7. PubMed ID: 3691005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dihydroergotamine--heparin in the prevention of thrombosis].
    Wille-Jørgensen PA
    Ugeskr Laeger; 1989 Oct; 151(40):2599. PubMed ID: 2815368
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ergotism in heparin-dihydroergotamine therapy].
    Schneck HJ; Tempel G; Kramann B
    Dtsch Med Wochenschr; 1983 Mar; 108(10):397. PubMed ID: 6825582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postoperative thrombosis prevention with heparin and dihydroergotamine].
    Fasshauer R
    Dtsch Med Wochenschr; 1983 Jun; 108(24):960. PubMed ID: 6851894
    [No Abstract]   [Full Text] [Related]  

  • 18. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasospastic reactions to heparin-dihydergot].
    Majer M; Wierichs R
    Dtsch Med Wochenschr; 1983 Apr; 108(16):640. PubMed ID: 6839987
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
    Cunningham M; de Torrenté A; Ekoé JM; Ackermann JP; Humair L
    Br J Surg; 1984 Nov; 71(11):829-31. PubMed ID: 6498453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.